Menocerin
Natural health product licensed in Canada
- Licence holder
- Botanica Research
- NPN or DIN-HM
- 80093388
- Status
- Active licence
- Licence date
- 17 July 2019
- Revision date
- 11 February 2025
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Dioscorea villosa L.: Les matières premières végétales doivent avoir subi les étapes traditionnelles d'épluchage, de lavage et de traitement thermique. L'absence d'alcaloïdes et de composés cyanogènes doit être démontrée par des bulletins d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Dioscorea villosa Source : Racine Potency : 2.5 mg Diosgenin | 15 mg | Not calculated |
| Extrait d'isoflavones de trèfle rouge Source : Trifolium pratense- Fleur | 400 mg | Not calculated |
| Extrait d'isoflavones de trèfle rouge Source : Extrait d'isoflavones de trèfle rouge | 400 mg | Not calculated |
| Rubus idaeus Source : Fruit | 50 mg | Not calculated |
| Extrait d'isoflavone de soja Source : Extrait d'isoflavone de soja | 30 mg | Not calculated |
| Extrait d'isoflavone de soja Source : Extrait d'isoflavone de soja | 12 mg ÉAI | Not calculated |
| Extrait d'isoflavone de soja Source : Glycine max - Graine | 30 mg | Not calculated |
| Extrait d'isoflavone de soja Source : Glycine max - Graine | 12 mg ÉAI | Not calculated |
| Cnicus benedictus Source : Sommité | 50 mg | Not calculated |
| Salvia officinalis Source : Feuille | 200 mg | Not calculated |
| Extrait d'isoflavones de trèfle rouge Source : Trifolium pratense- Fleur | 36 mg ÉAI | Not calculated |
| Extrait d'isoflavones de trèfle rouge Source : Extrait d'isoflavones de trèfle rouge | 36 mg ÉAI | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Stéarate de magnésium, Cellulose microcristalline, Gélatine, Resvératrol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Femmes ménopausées et en postménopause | minimum: 19 years | 1 Capsule | 2 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to help relieve premenstrual symptoms. Used in Herbal Medicine to help(s) relieve symptoms associated with menopause. Used in Herbal Medicine (as a hormone normaliser) to help stabilise menstrual cycle irregularities.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80093388
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.